SYBN:XETRA:XETRA-SPDR Barclays 10+ U.S. Corporate Bond UCITS (EUR)

ETF | Others |

Last Closing

USD 24.451

Change

-0.17 (-0.67)%

Market Cap

USD 0.10B

Volume

7.68K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.29 (+0.58%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.05 (+0.17%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.16 (+0.66%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.60 (+1.05%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

+0.58 (+0.42%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.70%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.28 (+0.55%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.54 (-0.11%)

USD 80.38B

ETFs Containing SYBN:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.46% 10% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.46% 10% F 16% F
Trailing 12 Months  
Capital Gain -3.49% 14% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.49% 14% F 23% F
Trailing 5 Years  
Capital Gain -13.76% 14% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.76% 13% F 20% F
Average Annual (5 Year Horizon)  
Capital Gain -5.25% 9% A- 13% F
Dividend Return -2.80% 19% F 20% F
Total Return 2.46% 49% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 8.36% 67% D+ 74% C
Risk Adjusted Return -33.44% 22% F 21% F
Market Capitalization 0.10B 34% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.